Antibacterial and antitumorigenic properties of microcin E492, a poreforming bacteriocin
Author
dc.contributor.author
Lagos Mónaco, Rosalba
Author
dc.contributor.author
Tello,
Author
dc.contributor.author
Mercado,
Author
dc.contributor.author
García,
Author
dc.contributor.author
Monasterio Opazo, Octavio
Admission date
dc.date.accessioned
2018-12-20T14:12:18Z
Available date
dc.date.available
2018-12-20T14:12:18Z
Publication date
dc.date.issued
2009
Cita de ítem
dc.identifier.citation
Current Pharmaceutical Biotechnology, Volumen 10, Issue 1, 2018, Pages 74-85
Identifier
dc.identifier.issn
13892010
Identifier
dc.identifier.issn
18734316
Identifier
dc.identifier.other
10.2174/138920109787048643
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/154715
Abstract
dc.description.abstract
Microcins are a family of low-molecular weight bacteriocins produced and secreted by Gram-negative bacteria. This review is focused on microcin E492, a pore-forming bacteriocin produced by Klebsiella pneumoniae RYC492 that exerts its antibacterial action on related strains. The steps necessary for the production of active microcin E492 involve post-translational modification with a catechol-type siderophore at the C-terminal and proteolytic processing during export to the extracellular space. This bacteriocin has a modular structure, with a toxic domain at the N-terminal and an uptake domain at the C-terminal of the mature protein. The mechanism by which the C-terminal of microcin E492 is recognized by catecholate siderophore receptors is called the "Trojan horse" strategy, because the C-terminal structure mimics essential bacterial elements, which are recognized by the respective receptors and translocated across the outer membrane to exert antibacterial action. The C-terminal uptake